|

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

RECRUITINGN/ASponsored by Petrovsky National Research Centre of Surgery
Actively Recruiting
PhaseN/A
SponsorPetrovsky National Research Centre of Surgery
Started2024-01-23
Est. completion2026-12-15
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06336213

Summary

According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

Thoracic aorta aneurysm/dissection

Exclusion Criteria:

Blood sample hemolysis

Conditions5

Aortic Aneurysm and DissectionCardiac Valve DiseaseHeart DiseaseThoracic Aortic AneurysmThoracic Aortic Dissection

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.